Advertisement
Screener

Standard BioTools Inc. (LAB) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Standard BioTools Inc. Operating Cash Flow

Standard BioTools Inc. (LAB) reported Operating Cash Flow of -$56.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05

  • Standard BioTools Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$10.31M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$46.60M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.19M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$22.20M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$74.34M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$143.45M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$43.29M.
  • Standard BioTools Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$89.37M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$10.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$56.91M
10-Q · filed 2026-08-05
-$58.10M
derived: sum of 3 quarters · filed 2026-08-05
-$80.30M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$46.60M
10-Q · filed 2026-05-06
-$47.79M
derived: sum of 2 quarters · filed 2026-05-06
-$69.99M
derived: sum of 3 quarters · filed 2026-05-06
-$90.66M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$23.39M
derived: sum of 2 quarters · filed 2026-03-16
-$44.06M
derived: sum of 3 quarters · filed 2026-08-05
-$74.34M
10-K · filed 2026-03-16
2025-09-30-$22.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$42.87M
derived: sum of 2 quarters · filed 2026-08-05
-$73.15M
10-Q · filed 2025-11-04
-$87.21M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$20.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$50.95M
10-Q · filed 2026-08-05
-$65.01M
derived: sum of 3 quarters · filed 2026-08-05
-$92.88M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$30.28M
10-Q · filed 2026-05-06
-$44.34M
derived: sum of 2 quarters · filed 2026-05-06
-$72.21M
derived: sum of 3 quarters · filed 2026-05-06
-$111.26M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$14.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$41.93M
derived: sum of 2 quarters · filed 2026-03-16
-$80.98M
derived: sum of 3 quarters · filed 2026-03-16
-$143.45M
10-K · filed 2026-03-16
2024-09-30-$27.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$66.92M
derived: sum of 2 quarters · filed 2025-11-04
-$129.40M
10-Q · filed 2025-11-04
-$143.46M
derived: sum of 4 quarters · filed 2026-03-16
2024-06-30-$39.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15
-$101.53M
10-Q · filed 2025-08-15
-$115.59M
derived: sum of 3 quarters · filed 2026-03-16
-$127.00M
derived: sum of 4 quarters · filed 2026-03-16
2024-03-31-$62.48M
10-Q · filed 2025-05-06
-$76.54M
derived: sum of 2 quarters · filed 2026-03-16
-$87.95M
derived: sum of 3 quarters · filed 2026-03-16
-$97.28M
derived: sum of 4 quarters · filed 2026-03-16
2023-12-31-$14.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$25.47M
derived: sum of 2 quarters · filed 2026-03-16
-$34.80M
derived: sum of 3 quarters · filed 2026-03-16
-$43.29M
10-K · filed 2026-03-16
2023-09-30-$11.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$20.74M
derived: sum of 2 quarters · filed 2024-11-06
-$29.23M
10-Q · filed 2024-11-06
-$48.41M
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30-$9.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$17.81M
10-Q · filed 2024-08-06
-$36.99M
derived: sum of 3 quarters · filed 2025-03-11
-$61.61M
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31-$8.48M
10-Q · filed 2024-05-09
-$27.67M
derived: sum of 2 quarters · filed 2025-03-11
-$52.28M
derived: sum of 3 quarters · filed 2025-03-11
-$82.27M
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31-$19.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
-$43.79M
derived: sum of 2 quarters · filed 2025-03-11
-$73.78M
derived: sum of 3 quarters · filed 2025-03-11
-$89.37M
10-K · filed 2025-03-11
2022-09-30-$24.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$54.60M
derived: sum of 2 quarters · filed 2023-11-07
-$70.19M
10-Q · filed 2023-11-07
-$77.19M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$29.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$45.58M
10-Q · filed 2023-08-08
-$52.58M
derived: sum of 3 quarters · filed 2023-08-08
-$62.07M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$15.59M
10-Q · filed 2023-05-09
-$22.59M
derived: sum of 2 quarters · filed 2023-05-09
-$32.09M
derived: sum of 3 quarters · filed 2023-05-09
-$46.75M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
-$16.50M
derived: sum of 2 quarters · filed 2023-03-14
-$31.16M
derived: sum of 3 quarters · filed 2023-03-14
-$44.06M
10-K · filed 2023-03-14
2021-09-30-$9.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$24.16M
derived: sum of 2 quarters · filed 2022-11-09
-$37.06M
10-Q · filed 2022-11-09
-$40.79M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$14.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$27.57M
10-Q · filed 2022-08-09
-$31.30M
derived: sum of 3 quarters · filed 2022-08-09
-$35.90M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$12.90M
10-Q · filed 2022-05-09
-$16.63M
derived: sum of 2 quarters · filed 2022-05-09
-$21.23M
derived: sum of 3 quarters · filed 2022-05-09
-$24.02M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
-$8.33M
derived: sum of 2 quarters · filed 2022-03-08
-$11.12M
derived: sum of 3 quarters · filed 2022-03-08
-$15.42M
10-K · filed 2022-03-08
2020-09-30-$4.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$7.39M
derived: sum of 2 quarters · filed 2021-11-09
-$11.68M
10-Q · filed 2021-11-09
-$17.20M
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30-$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$7.08M
10-Q · filed 2021-08-06
-$12.60M
derived: sum of 3 quarters · filed 2022-03-08
-$17.15M
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31-$4.29M
10-Q · filed 2021-05-07
-$9.81M
derived: sum of 2 quarters · filed 2022-03-08
-$14.36M
derived: sum of 3 quarters · filed 2022-03-08
-$19.38M
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31-$5.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
-$10.07M
derived: sum of 2 quarters · filed 2022-03-08
-$15.08M
derived: sum of 3 quarters · filed 2022-03-08
-$35.21M
10-K · filed 2022-03-08
2019-09-30-$4.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$9.56M
derived: sum of 2 quarters · filed 2020-11-09
-$29.69M
10-Q · filed 2020-11-09
-$30.33M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$5.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$25.14M
10-Q · filed 2020-08-07
-$25.78M
derived: sum of 3 quarters · filed 2021-02-25
-$29.84M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$20.13M
10-Q · filed 2020-05-11
-$20.77M
derived: sum of 2 quarters · filed 2021-02-25
-$24.83M
derived: sum of 3 quarters · filed 2021-02-25
-$29.16M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$638.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$4.70M
derived: sum of 2 quarters · filed 2021-02-25
-$9.03M
derived: sum of 3 quarters · filed 2021-02-25
-$25.20M
10-K · filed 2021-02-25
2018-09-30-$4.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$8.39M
derived: sum of 2 quarters · filed 2019-11-08
-$24.56M
10-Q · filed 2019-11-08
-$23.90M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$4.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$20.50M
10-Q · filed 2019-08-07
-$19.84M
derived: sum of 3 quarters · filed 2020-02-27
-$27.82M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$16.18M
10-Q · filed 2019-05-07
-$15.52M
derived: sum of 2 quarters · filed 2020-02-27
-$23.50M
derived: sum of 3 quarters · filed 2020-02-27
-$31.79M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$661.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$7.32M
derived: sum of 2 quarters · filed 2020-02-27
-$15.61M
derived: sum of 3 quarters · filed 2020-02-27
-$24.10M
10-K · filed 2020-02-27
2017-09-30-$7.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$16.27M
derived: sum of 2 quarters · filed 2018-11-06
-$24.76M
10-Q · filed 2018-11-06
-$35.49M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$8.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$16.78M
10-Q · filed 2018-08-08
-$27.51M
derived: sum of 3 quarters · filed 2019-03-18
-$40.77M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$8.49M
10-Q · filed 2018-05-08
-$19.22M
derived: sum of 2 quarters · filed 2019-03-18
-$32.48M
derived: sum of 3 quarters · filed 2019-03-18
-$39.83M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31-$10.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$23.99M
derived: sum of 2 quarters · filed 2019-03-18
-$31.35M
derived: sum of 3 quarters · filed 2019-03-18
-$39.14M
10-K · filed 2019-03-18
-$39.10M
10-K · filed 2017-03-03
2016-09-30-$13.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$20.62M
derived: sum of 2 quarters · filed 2017-11-07
-$28.41M
10-Q · filed 2017-11-07
-$28.38M
10-Q · filed 2016-11-09
-$32.81M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30-$7.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$15.15M
10-Q · filed 2017-08-08
-$19.55M
derived: sum of 3 quarters · filed 2018-03-08
-$32.25M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31-$7.79M
10-Q · filed 2017-05-09
-$12.20M
derived: sum of 2 quarters · filed 2018-03-08
-$24.90M
derived: sum of 3 quarters · filed 2018-03-08
-$32.73M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31-$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
-$17.10M
derived: sum of 2 quarters · filed 2018-03-08
-$24.93M
derived: sum of 3 quarters · filed 2018-03-08
-$34.73M
10-K · filed 2018-03-08
-$34.70M
10-K · filed 2016-02-29
2015-09-30-$12.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$20.53M
derived: sum of 2 quarters · filed 2016-11-09
-$30.33M
10-Q · filed 2016-11-09
-$33.85M
derived: sum of 4 quarters · filed 2017-03-03
2015-06-30-$7.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$17.63M
10-Q · filed 2016-08-09
-$21.15M
derived: sum of 3 quarters · filed 2017-03-03
-$30.02M
derived: sum of 4 quarters · filed 2017-03-03
2015-03-31-$9.80M
10-Q · filed 2016-05-09
-$13.32M
derived: sum of 2 quarters · filed 2017-03-03
-$22.19M
derived: sum of 3 quarters · filed 2017-03-03
-$21.88M
derived: sum of 4 quarters · filed 2017-03-03
2014-12-31-$3.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
-$12.39M
derived: sum of 2 quarters · filed 2017-03-03
-$12.08M
derived: sum of 3 quarters · filed 2017-03-03
-$22.62M
10-K · filed 2017-03-03
2014-09-30-$8.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$8.55M
derived: sum of 2 quarters · filed 2015-11-09
-$19.10M
10-Q · filed 2015-11-09
-$15.86M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$312.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$10.23M
10-Q · filed 2015-08-10
-$7.00M
derived: sum of 3 quarters · filed 2016-02-29
-$8.30M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$10.55M
10-Q · filed 2015-05-11
-$7.31M
derived: sum of 2 quarters · filed 2016-02-29
-$8.62M
derived: sum of 3 quarters · filed 2016-02-29
-$11.25M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$3.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.93M
derived: sum of 2 quarters · filed 2016-02-29
-$707.00K
derived: sum of 3 quarters · filed 2016-02-29
-$1.59M
10-K · filed 2016-02-29
2013-09-30-$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
-$3.94M
derived: sum of 2 quarters · filed 2014-11-06
-$4.83M
10-Q · filed 2014-11-06
-$8.33M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30-$2.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04
-$3.52M
10-Q · filed 2014-08-04
-$7.02M
derived: sum of 3 quarters · filed 2015-02-26
-$10.36M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31-$884.00K
10-Q · filed 2014-05-12
-$4.38M
derived: sum of 2 quarters · filed 2015-02-26
-$7.72M
derived: sum of 3 quarters · filed 2015-02-26
-$11.72M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31-$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
-$6.83M
derived: sum of 2 quarters · filed 2015-02-26
-$10.84M
derived: sum of 3 quarters · filed 2015-02-26
-$17.48M
10-K · filed 2015-02-26
2012-09-30-$3.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$7.34M
derived: sum of 2 quarters · filed 2013-11-07
-$13.98M
10-Q · filed 2013-11-07
-$16.23M
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30-$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
-$10.64M
10-Q · filed 2013-08-07
-$12.90M
derived: sum of 3 quarters · filed 2014-03-12
-$15.28M
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31-$6.64M
10-Q · filed 2013-05-09
-$8.90M
derived: sum of 2 quarters · filed 2014-03-12
-$11.28M
derived: sum of 3 quarters · filed 2014-03-12
-$22.96M
derived: sum of 4 quarters · filed 2014-03-12
2011-12-31-$2.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12
-$4.63M
derived: sum of 2 quarters · filed 2014-03-12
-$16.31M
derived: sum of 3 quarters · filed 2014-03-12
-$17.54M
10-K · filed 2014-03-12
2011-09-30-$2.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$14.06M
derived: sum of 2 quarters · filed 2012-11-09
-$15.29M
10-Q · filed 2012-11-09
-$17.55M
derived: sum of 4 quarters · filed 2013-03-12
2011-06-30-$11.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
-$12.91M
10-Q · filed 2012-08-14
-$15.17M
derived: sum of 3 quarters · filed 2013-03-12
-$18.39M
derived: sum of 4 quarters · filed 2013-03-12
2011-03-31-$1.23M
10-Q · filed 2012-05-15
-$3.49M
derived: sum of 2 quarters · filed 2013-03-12
-$6.71M
derived: sum of 3 quarters · filed 2013-03-12
2010-12-31-$2.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12
-$5.48M
derived: sum of 2 quarters · filed 2013-03-12
-$11.51M
10-K · filed 2013-03-12
2010-09-30-$3.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$9.25M
10-Q · filed 2011-11-14
2010-06-30-$6.03M
10-Q · filed 2011-08-09
2009-12-31-$19.51M
10-K · filed 2012-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01